Oracle Investment Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-195,000
Closed -$2.25M 23
2017
Q4
$2.25M Hold
195,000
0.45% 17
2017
Q3
$3.71M Sell
195,000
-494,002
-72% -$10.2M 0.61% 13
2017
Q2
$16.6M Sell
689,002
-5,900
-0.8% -$129K 2.62% 10
2017
Q1
$13.8M Sell
694,902
-133,073
-16% -$2.97M 2.15% 11
2016
Q4
$19.9M Buy
827,975
+159,369
+24% +$4.44M 3.31% 10
2016
Q3
$18.6M Buy
668,606
+204,941
+44% +$5.42M 2.86% 10
2016
Q2
$11.3M Buy
463,665
+56,302
+14% +$1.6M 2.63% 12
2016
Q1
$13.7M Sell
407,363
-533,615
-57% -$16.8M 3.56% 10
2015
Q4
$28.1M Buy
940,978
+128,857
+16% +$4.34M 4.87% 9
2015
Q3
$25.6M Sell
812,121
-72,270
-8% -$3.53M 5.24% 7
2015
Q2
$42.8M Buy
884,391
+159,707
+22% +$6.73M 5.19% 8
2015
Q1
$31.4M Buy
724,684
+339,110
+88% +$12.2M 3.99% 10
2014
Q4
$10.1M Hold
385,574
1.33% 18
2014
Q3
$6.85M Hold
385,574
0.95% 19
2014
Q2
$9.26M Sell
385,574
-189,909
-33% -$3.85M 1.12% 19
2014
Q1
$14.5M Sell
575,483
-11,995
-2% -$332K 1.65% 18
2013
Q4
$13.4M Buy
587,478
+574,922
+4,579% +$11.6M 1.84% 16
2013
Q3
$284K Buy
+12,556
New +$290K 0.04% 26

Other funds holding PGEN

Oracle Investment Management's PGEN Position: Q1 2018 in Review

Oracle Investment Management sold out of Precigen (PGEN) in Q1 2018, closing a stake of 195,000 shares — an estimated $2.25M sold.

Oracle Investment Management first reported a position in PGEN in Q3 2013 and held it in 18 quarters. The position peaked at $42.8M in Q2 2015. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2018.

  • Oracle Investment Management reported no remaining Precigen position as of Q1 2018 after selling out during the quarter.
  • Oracle Investment Management sold 195,000 Precigen shares in Q1 2018, an estimated $2.25M.
  • Oracle Investment Management first reported a position in Precigen in Q3 2013 and held it in 18 quarters.
  • Oracle Investment Management's Precigen position peaked at $42.8M in Q2 2015.
  • 166 funds tracked by Wall St. Rank held Precigen as of Q1 2018.

Based on Oracle Investment Management's 13F filing for Q1 2018, filed 15 May 2018.